Case Study

Modular Innovation: Expanding CDMO Advanced Therapy Manufacturing Capability With BSL-2LS cGMP Facility

Source: Germfree

In a strategic move to enhance their manufacturing capabilities, ArrantaBio (now Inceptor Bio) partnered with Germfree to establish a cutting-edge BSL-2LS cGMP facility in Gainesville, FL. This 4,000 sq. ft. plant features a unique open ballroom design constructed from five prefabricated modules, providing a flexible and adaptable environment tailored to the evolving needs of a CDMO. With robust engineering controls and unidirectional process flow, the facility ensures top-tier production standards.

Discover how Germfree’s modular innovation facilitated a seamless expansion, meeting rigorous standards and offering unparalleled adaptability for advanced therapy manufacturing.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online